Key Takeaways:  Indian dermocosmetics brand Chosen raised $5 million.The skincare brand has created a unique clinic-to-consumer model based on over 150,000 dermatological consultations.The round was led by Fireside Ventures, with participation from L’Oréal’s venture arm BOLD and Alkemi Growth Capital.Investors are betting on the growing demand for clinically backed skincare in India, where dermocosmetics are gaining traction.WHO: Founded in 2020 by cosmetic dermatologist Dr. Renita Rajan, a recognized key opinion leader in dermatological beauty and laser technologies in India, Chosen focuses on skincare designed for melanin-rich Indian skin, grounded in exposome science and focused on four key domains of aging: pigmentation, skin texture, contour, and hair aging. Its portfolio spans both topical formulations and nutraceuticals. The brand has built its product and treatment approach based on insights from more than 150,000 consultations. It operates through a hybrid model that combines a network of dermatologists with a direct-to-consumer platform. The product profile of 58 stock-keeping units is prescribed in over 2,000 clinics across India, while its digital platform caters to customers nationwide. WHY: The funds will be deployed to strengthen Chosen's R&D capabilities, expand its product pipeline, scale its Centre of Excellence, and invest in talent across functions.IN THEIR OWN WORDS: Dr. Renita Rajan, founder and CEO of Chosen, stated, “Indian dermatologists have contributed significantly to therapeutic dermatology, but personal care has been left behind, shaped largely by market trends borrowed from circumstances that aren’t ours.